Connor, Clark & Lunn Investment Management (CC&L)’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,304
| Closed | -$4.05M | – | 1671 |
|
|
2024
Q2 | $4.05M | Sell |
12,304
-6,061
| -33% | -$2M | 0.02% | 476 |
|
|
2024
Q1 | $7.27M | Buy |
18,365
+16,016
| +682% | +$6.34M | 0.03% | 357 |
|
|
2023
Q4 | $827K | Sell |
2,349
-10,545
| -82% | -$3.71M | ﹤0.01% | 913 |
|
|
2023
Q3 | $4.84M | Sell |
12,894
-36,410
| -74% | -$13.7M | 0.03% | 407 |
|
|
2023
Q2 | $18.9M | Sell |
49,304
-39,726
| -45% | -$15.2M | 0.09% | 160 |
|
|
2023
Q1 | $30.8M | Buy |
89,030
+26,733
| +43% | +$9.26M | 0.17% | 110 |
|
|
2022
Q4 | $14.7M | Buy |
62,297
+58,477
| +1,531% | +$13.8M | 0.08% | 178 |
|
|
2022
Q3 | $940K | Sell |
3,820
-3,440
| -47% | -$846K | 0.01% | 675 |
|
|
2022
Q2 | $2.2M | Buy |
7,260
+4,430
| +157% | +$1.34M | 0.01% | 453 |
|
|
2022
Q1 | $1.16M | Buy |
2,830
+1,311
| +86% | +$538K | 0.01% | 628 |
|
|
2021
Q4 | $712K | Buy |
+1,519
| New | +$712K | ﹤0.01% | 734 |
|
|
2021
Q2 | – | Sell |
-7,173
| Closed | -$2.02M | – | 1124 |
|
|
2021
Q1 | $2.02M | Buy |
+7,173
| New | +$2.02M | 0.01% | 558 |
|
|
2020
Q4 | – | Sell |
-4,029
| Closed | -$1.11M | – | 1059 |
|
|
2020
Q3 | $1.11M | Buy |
4,029
+1,068
| +36% | +$294K | 0.01% | 601 |
|
|
2020
Q2 | $673K | Buy |
+2,961
| New | +$673K | ﹤0.01% | 696 |
|